XIAO-I's Reverse Split Can't Stop the Bleeding — Can This AI Stock Find a Floor?

Shares of XIAO-I Corporation (AIXI) cratered 7.9% to $11.60 on June 2, extending a punishing slide that has wiped out roughly 19% of the stock's value in just five trading sessions. The selloff is stock-specific — broader markets traded slightly higher — and lands squarely on a micro-cap Chinese AI company already fighting to keep its Nasdaq listing alive. XIAO-I's Reverse Split Can't Stop the Bleeding — Can This AI Stock Find a Floor?

Shares of XIAO-I Corporation (AIXI) cratered 7.9% to $11.60 on June 2, extending a punishing slide that has wiped out roughly 19% of the stock's value in just five trading sessions. The selloff is stock-specific — broader markets traded slightly higher — and lands on a micro-cap Chinese AI company already fighting to stay listed on Nasdaq.

The Reverse Split Was a Survival Move, Not a Growth Signal. XIAO-I changed its ADS ratio from one ADS representing three ordinary shares to one ADS representing sixty ordinary shares — effectively a one-for-twenty reverse split — on May 11. The purpose was blunt: the company received two Nasdaq deficiency notices in December 2025 for trading below the $1.00 minimum bid price for 30 consecutive days and for its publicly held shares falling below the $15 million market-value floor.

Nasdaq granted compliance deadlines expiring June 15–16, 2026 — just two weeks from today. The split mechanically boosted the per-share price but created zero new value, and the stock has been sliding ever since.

The Financial Foundations Are Fragile. XIAO-I carries a financial-health score of just 28 out of 100 and a financial-strength rating of 2 out of 10, reflecting high debt and ongoing operational losses.

InvestingPro pegged the market cap at roughly $9.5 million pre-split and rated overall financial health as "WEAK."

No insider buying or selling has been reported in the past year , a signal that even management isn't putting personal capital behind the stock at these levels.

A Patent Win Over Apple Sparked a Sugar High. AIXI surged 515% in a single session after China's Supreme Court upheld the company's AI patents against Apple. But that momentum evaporated fast. The patent infringement proceedings against Apple remain active with no confirmed schedule for damages. Until a cash settlement materializes — if one ever does — the legal victory adds no revenue.

The Compliance Clock Is Still Ticking. Although the company regained compliance with Nasdaq's market-value rule in April, it cautioned there is "no assurance" it can maintain compliance. With the stock plunging toward single digits just days before the June 16 bid-price deadline, delisting risk is re-emerging. For shareholders, the math is unforgiving: a reverse split followed by continued selling means fewer shares losing value faster — the worst of both worlds.